Your browser doesn't support javascript.
loading
Optimization of transgenesis conditions for the generation of CXCL2-luciferase reporter mice line
Crispo, Martina; Schlapp, Geraldine; Cárdenas-Rodríguez, Magdalena; González-Maciel, Dolores; Rumbo, Martín.
Affiliation
  • Crispo, Martina; Institut Pasteur de Montevideo. Unidadde Animales Transgénicos y de Experimentación. Montevideo. UY
  • Schlapp, Geraldine; Institut Pasteur de Montevideo. Unidadde Animales Transgénicos y de Experimentación. Montevideo. UY
  • Cárdenas-Rodríguez, Magdalena; Institut Pasteur de Montevideo. Unidadde Animales Transgénicos y de Experimentación. Montevideo. UY
  • González-Maciel, Dolores; Institut Pasteur de Montevideo. Unidadde Animales Transgénicos y de Experimentación. Montevideo. UY
  • Rumbo, Martín; Institut Pasteur de Montevideo. Unidadde Animales Transgénicos y de Experimentación. Montevideo. UY
Electron. j. biotechnol ; Electron. j. biotechnol;16(6): 14-14, Nov. 2013. ilus, tab
Article in En | LILACS | ID: lil-696555
Responsible library: CL1.1
ABSTRACT

Background:

Transgenesis by microinjection has been widely used for the generation of different mouse models. Different variables of the procedure may critically affect the efficiency of the process. A DNA construction that carries the CXCL2 promoter gene and firefly luciferase has been used to optimize aspects of the procedure. Three different concentrations (0.5, 1.0 and 4.0 ng/µl) of the DNA construction to microinject a total of 1981 zygotes has been tested. Intact/injected embryos, pregnancy and birth rate, survival of pups 7 days after birth, number of transgenic pups and overall transgenic efficiency was registered and analyzed by Z test of proportions for each group.

Results:

A total of seven transgenic founders were detected for the three DNA concentrations used, 1 in 46 alive pups in the 0.5 ng/µl group, 5 in 38 alive pups in the 1 ng/µl group and 1 in 21 alive pups in the 4 ng/µl group ( p < 0.1). The overall transgenic efficiency was higher for the 1 ng/µl concentration, with a transgenic rate of 13.2%.

Conclusions:

In conclusion, we have selected the best operative conditions to maximize the transgenesis efficiency. Furthermore, the transgenic lines developed could be used as a reporter model of innate immunity activation with many different applications in the fields of immunology, cancer and neurodegenerative diseases.
Subject(s)
Key words

Full text: 1 Index: LILACS Main subject: Gene Transfer Techniques / Chemokine CXCL2 / Luciferases Type of study: Prognostic_studies Limits: Animals Language: En Journal: Electron. j. biotechnol Journal subject: BIOTECNOLOGIA Year: 2013 Type: Article

Full text: 1 Index: LILACS Main subject: Gene Transfer Techniques / Chemokine CXCL2 / Luciferases Type of study: Prognostic_studies Limits: Animals Language: En Journal: Electron. j. biotechnol Journal subject: BIOTECNOLOGIA Year: 2013 Type: Article